Background: Despite 20 years of ivermectin mass distribution in the Mahenge area, Tanzania, the prevalence of onchocerciasis and epilepsy has remained high in rural villages. We investigated the efficacy of ivermectin in reducing Onchocerca volvulus microfilariae and predictors for parasitic load following ivermectin treatment in persons with and without epilepsy in two rural villages.Methods: Between April and September 2019, 50 persons with epilepsy (PWE) and 160 randomly selected persons without epilepsy (PWOE) from Msogezi and Mdindo villages participated in a follow-up study. Skin snips were obtained pre- (baseline) and three months post-ivermectin treatment.Results: The overall prevalence of O. volvulus positive skin snips at baseline was 49% (103/210), with no significant difference between PWE (58.0%) and PWOE (46.3%); p=0.197. The overall median microfilarial density was significantly higher at baseline (0.0 mf/mg, IQR: 0.0-1.7) than three month post-ivermectin treatment (0.0 mf/mg, IQR: 0.0-0.0), p<0.001. Three months after ivermectin, the microfilarial density had decreased by ≥80% in 54 (81.8%, 95%CI: 72.3-91.4) of the 66 individuals with positive skin snips at baseline. High microfilarial density at baseline was the only significant predictor associated with higher microfilarial density in the post-ivermectin skin snips. Conclusion: Our study reports a satisfactory decrease in microfilarial density following ivermectin treatment in most individuals. This suggests that optimizing ivermectin coverage will address the ongoing onchocerciasis transmission in Mahenge.